Collaboration with CSEM will speed up identification of suitable soluble TCR candidates Engimmune’s executive team will be presenting at Biotech Showcase in San Francisco in January BASEL, Switzerland, Dec. 13, 2023 /PRNewswire/ — Engimmune Therapeutics AG (“Engimmune”), a world-class…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.